Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
Hippocratic AI raises $141M for creating patient-facing AI agents

From TechCrunch

By Marina Temkin

January 10, 2025

Hippocratic AI raises $141M for creating patient-facing AI agents

Hippocratic AI raises $141M for creating patient-facing AI agents

Hippocratic AI, a startup building AI solutions that can handle non-diagnostic patient-facing tasks, secured a massive $141 million Series B at a valuation of $1.64 billion led by Kleiner Perkins, the company announced Thursday. The funding comes nine months after Hippocratic AI raised a $53 million round from General Catalyst and Andreessen Horowitz and five months after raising $17 million from Nvidia. The startup is less than two years old.

While most healthcare-generative AI companies focus on reducing administrative burdens, Hippocratic AI addresses the shortage of healthcare professionals by creating agents that can perform simple tasks like pre-operating procedures, remote patient monitoring, and appointment preparation.

In 2024, the startup has signed contracts with 23 health systems and insurers. Hippocratic is using new capital to expand the product into more markets and internationally.

View original article on techcrunch.com

Most Recent

Neil Rimer thinks the AI money is coming back out

Neil Rimer thinks the AI money is coming back out

Neil Rimer, the venture capitalist who co-founded Index Ventures, predicts the historic wealth AI is generating in Silicon Valley will have to be redistributed, voluntarily or involuntarily.

Jul 17, 2026

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks has remade its image into an AI company and has published research on the cost savings of open weight AI models for coding.

Jul 17, 2026

Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation

Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation

The potential deal highlights a growing trend of complex, multi-stage funding rounds that mask true entry prices.

Jul 17, 2026

AI-powered travel agency Fora hits unicorn status, raises $60M

AI-powered travel agency Fora hits unicorn status, raises $60M

Travel agency Fora announced a $60 million Series D round led by Forerunner and Tactile Ventures, valuing the company at $1 billion.

Jul 16, 2026

Similar Posts

Hippocratic is building a large language model for healthcare

Hippocratic is building a large language model for healthcare

AI, specifically generative AI, has the potential to transform healthcare. At least, that sales pitch from Hippocratic Health, which emerged from stealth today with a whopping $50 million in seed financing behind it and a valuation in the “triple digit millions.” The tranche, co-led by General Catalyst and Andreessen Horowitz, is a big vote of […]

May 16, 2023

Innovaccer aims to become healthcare’s AI powerhouse with $275M Series F

Innovaccer aims to become healthcare’s AI powerhouse with $275M Series F

When it comes to data, perhaps no sector has as much of it and in as many distinct silos as the healthcare industry. Hundreds of millions of patient records reside within various electronic health records (EHRs) maintained by vendors like Epic, Cerner and Athena. Insurance companies hold extensive data sets on coverage, reimbursement rates, and patient demographics. Pharmacies and laboratories contribute further data points on medication usage and diagnostic results. Over the last decade or so

Jan 9, 2025

Anthropic raises $450M to build next-gen AI assistants

Anthropic raises $450M to build next-gen AI assistants

Anthropic, the prominent generative AI startup co-founded by OpenAI veterans, has raised $450 million in a Series C funding round led by Spark Capital. Anthropic wouldn’t disclose what the round valued its business at. But The Information reported in early March (and as confirmed by us when we were leaked the pitch deck for the […]

May 23, 2023

Healthcare analytics platform H1 has acquired Ribbon, backed by a16Z and General Catalyst

Healthcare analytics platform H1 has acquired Ribbon, backed by a16Z and General Catalyst

H1, a healthcare data analytics platform serving the pharmaceutical industry with data on over 10 million healthcare professionals, has acquired Ribbon, a startup that helps patients find doctors that are supported by their insurance. Financial terms of the deal have not been disclosed. The last time that Ribbon — founded in 2016 and a Y Combinator alum — raised money was in 2021, when it closed a $43.5 million Series B that valued it at $283.5 million, per PitchBook data. Many startups that h

Jan 8, 2025

Most Recent

Neil Rimer thinks the AI money is coming back out

Neil Rimer thinks the AI money is coming back out

Neil Rimer, the venture capitalist who co-founded Index Ventures, predicts the historic wealth AI is generating in Silicon Valley will have to be redistributed, voluntarily or involuntarily.

Jul 17, 2026

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks has remade its image into an AI company and has published research on the cost savings of open weight AI models for coding.

Jul 17, 2026

Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation

Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation

The potential deal highlights a growing trend of complex, multi-stage funding rounds that mask true entry prices.

Jul 17, 2026

AI-powered travel agency Fora hits unicorn status, raises $60M

AI-powered travel agency Fora hits unicorn status, raises $60M

Travel agency Fora announced a $60 million Series D round led by Forerunner and Tactile Ventures, valuing the company at $1 billion.

Jul 16, 2026

Similar Posts

Hippocratic is building a large language model for healthcare

Hippocratic is building a large language model for healthcare

AI, specifically generative AI, has the potential to transform healthcare. At least, that sales pitch from Hippocratic Health, which emerged from stealth today with a whopping $50 million in seed financing behind it and a valuation in the “triple digit millions.” The tranche, co-led by General Catalyst and Andreessen Horowitz, is a big vote of […]

May 16, 2023

Innovaccer aims to become healthcare’s AI powerhouse with $275M Series F

Innovaccer aims to become healthcare’s AI powerhouse with $275M Series F

When it comes to data, perhaps no sector has as much of it and in as many distinct silos as the healthcare industry. Hundreds of millions of patient records reside within various electronic health records (EHRs) maintained by vendors like Epic, Cerner and Athena. Insurance companies hold extensive data sets on coverage, reimbursement rates, and patient demographics. Pharmacies and laboratories contribute further data points on medication usage and diagnostic results. Over the last decade or so

Jan 9, 2025

Anthropic raises $450M to build next-gen AI assistants

Anthropic raises $450M to build next-gen AI assistants

Anthropic, the prominent generative AI startup co-founded by OpenAI veterans, has raised $450 million in a Series C funding round led by Spark Capital. Anthropic wouldn’t disclose what the round valued its business at. But The Information reported in early March (and as confirmed by us when we were leaked the pitch deck for the […]

May 23, 2023

Healthcare analytics platform H1 has acquired Ribbon, backed by a16Z and General Catalyst

Healthcare analytics platform H1 has acquired Ribbon, backed by a16Z and General Catalyst

H1, a healthcare data analytics platform serving the pharmaceutical industry with data on over 10 million healthcare professionals, has acquired Ribbon, a startup that helps patients find doctors that are supported by their insurance. Financial terms of the deal have not been disclosed. The last time that Ribbon — founded in 2016 and a Y Combinator alum — raised money was in 2021, when it closed a $43.5 million Series B that valued it at $283.5 million, per PitchBook data. Many startups that h

Jan 8, 2025